5 stocks to buy with £20k in a Stocks and Shares ISA

Rupert Hargreaves looks at five stocks he’d buy today for his Stocks and Shares ISA with £20,000 and a long-term outlook.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Using a Stocks and Shares ISA is one of the best ways to invest in the market. Any income or capital gains earned on assets held within one of these wrappers doesn’t attract any further tax. Investors don’t even need to declare the income on their tax returns.

I try to make the most of my £20k ISA allowance every year as soon as possible. Here are five stocks I’d buy with my latest allowance today.

Stocks and Shares ISA

Thanks to the tax benefits of an ISA, I think they’re the perfect wrappers in which to own income investments.

I’d buy FTSE 100 healthcare stocks Hikma and GlaxoSmithKline with a portion of my £20,000 investment on this theme. 

Hikma manufactures a range of generic, low-cost medications. Meanwhile, Glaxo is more of a healthcare conglomerate, with treatments spanning from vaccines to oncology and an extensive consumer healthcare portfolio. This mixture provides healthy cash flows to support the firm’s large dividend yield of 5.6%. 

Hikma is more of a dividend growth investment. The stock offers a dividend yield of 1.5%, at the time of writing. Over the past five years, as the company’s earnings have expanded, its per-share dividend has grown at a compound annual rate of nearly 10%. As such, over the long term, I think this could be a fantastic income investment. 

Of course, these assets aren’t risk-free. Dividends are paid out of profits, and if the income at Glaxo or Hikma falls, the payouts could be slashed. Any number of factors could lead to this outcome. A sudden unforeseen economic downturn, legal battle, or higher than expected costs could significantly reduce earnings power. 

Despite these risks, I’d buy Glaxo and Hikma for my Stocks and Shares ISA portfolio today. 

Steady income 

Two other income plays I’d buy are Assura and Airtel Africa. Assura owns medical facilities in the UK, which it leases to healthcare providers. Airtel owns mobile phone towers across Africa.

The stocks offer dividend yields of 3.7% and 4.9% respectively. These payouts aren’t guaranteed. Both companies also use a lot of debt to fund their operations, which could limit their ability to grow the distributions in the long run. 

Still, I’d buy the equities for my Stocks and Shares ISA due to their cash flows from stable infrastructure assets. 

Growth investment 

The final company I’d buy for my £20,000 portfolio is a growth investment. Spirent Communications develops technology for the communications industry, in particular equipment used in 5G networks.

The 5G global services market is expected to grow at a compound annual growth rate of 46.2% from 2021 to 2028. I think if Spirent can grab just a tiny share of this market, it could be an excellent growth investment. 

The main challenge the business faces is standing out in such a competitive market. The market may also not live up to growth expectations. This could mean Spirent’s long-term growth is lower than expected. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Illustration of flames over a black background
Investing Articles

Just released: May’s higher-risk, high-reward stock recommendation [PREMIUM PICKS]

Fire ideas will tend to be more adventurous and are designed for investors who can stomach a bit more volatility.

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

Why now could be the time to buy these recovering FTSE 100 growth shares!

Royston Wild is building a list of the FTSE's greatest shares to buy today. Here are two he thinks could…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

My Stocks and Shares ISA has two giant weeds in it. Should I pull them out?

This writer has two massive losers inside his Stocks and Shares ISA portfolio. What's gone wrong? And is it time…

Read more »

Mature black couple enjoying shopping together in UK high street
Investing Articles

7.5% dividend yield! 2 cheap passive income stocks to consider for a £1,500 payout

Royston Wild describes how large investment in these passive income stocks could provide a four-figure cash payout this year.

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

Billionaires are selling Nvidia stock! I’d rather buy this AI share instead

With billionaire investors now banking profits in Nvidia stock, our writer considers an AI share that still looks to be…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

3 shares that could soar as the UK stock market wakes from its slumber

The UK stock market is on fire at the moment. If it keeps rising from here, Edward Sheldon reckons these…

Read more »

View of Tower Bridge in Autumn
Investing Articles

The FTSE 100 is on fire! 2 top shares I’d still snap up

FTSE 100 shares as a whole might be setting records on a daily basis this month, but that doesn't mean…

Read more »

Young Black man sat in front of laptop while wearing headphones
Investing Articles

£11,000 in savings? Here’s how I’d aim to turn that into a £15,080-a-year second income

Buying dividend shares is how this Fool continues to build up his second income. With a lump sum of savings,…

Read more »